The AI ‘Slowdown’ Is an Antitrust Mess

Leading AI companies face potential antitrust scrutiny for proposing a coordinated development "slowdown" to address safety risks. Legal experts suggest that framing these efforts as anticompetitive output reduction creates unnecessary regulatory risk. Instead, companies could justify collaborative safety protocols under the ancillary restraints doctrine, which protects agreements that prevent catastrophic outcomes and promote long-term competition.